Loading organizations...
Sofinim is a private equity firm that specializes in providing growth capital, facilitating management buyouts, and supporting management buy-ins. The firm focuses its investments on industrial and service-oriented companies that demonstrate significant growth potential, applying a strategy that emphasizes operational excellence to nurture its portfolio. It functions as an investment vehicle dedicated to fostering the development and expansion of promising enterprises.
Sofinim NV was established in 1988 as a private equity entity. Its strategic importance within the Belgian investment landscape grew, and by 1994, it became integral to Ackermans & Van Haaren's growth capital initiatives following the acquisition of the privatized Société Nationale d'Investissement. This integration solidified its role as a key player in providing capital and strategic support to companies seeking expansion and structural changes.
The firm targets a diverse range of industrial and service-oriented companies seeking capital to realize their expansion goals. Sofinim's long-term vision centers on being a collaborative financial partner, aiming to unlock and accelerate the growth trajectories of its investee companies through active engagement and a focus on robust operational improvements, thereby generating sustained value for its stakeholders.
Sofinim has 2 tracked investments across 1 company. The latest tracked deal is $20.6M Series B in OncoDNA in February 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 14, 2020 | OncoDNA | $20.6M Series B | Robert Schier, GUY Geldhof | CPH Bank, Inventures, Sambrinvest, Fontaine François, Sriw |
| Sep 4, 2016 | OncoDNA | $8.6M Other Equity | — | Crown Predator Holdings, Inventures, Invest4OncoDNA, Ipg/bio.be, Sambrinvest, Sriw, Vinsovier |